We are live on
!
Find out more
PAM
Panagora Asset Management Portfolio holdings
AUM
$32.6B
1-Year Est. Return
52.29%
This Fund
S&P 500
This Quarter
Est. Return
+10.18%
1 Year Est. Return
+52.29%
3 Year Est. Return
+171.1%
5 Year Est. Return
+242.78%
10 Year Est. Return
+962.16%
AUM
$17.8B
AUM Growth
+$911M
(+5.4%)
Cap. Flow
-$368M
Cap. Flow
% of AUM
-2.07%
Top 10 Holdings %
Top 10 Hldgs %
23.09%
Holding
3,154
New
338
Increased
1,006
Reduced
790
Closed
311
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$69.1M |
| 2 |
Citigroup
C
|
+$66.4M |
| 3 |
3M
MMM
|
+$62.2M |
| 4 |
Home Depot
HD
|
+$50.7M |
| 5 |
Agilent Technologies
A
|
+$49.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$90.6M |
| 2 |
Merck
MRK
|
+$74.3M |
| 3 |
Allstate
ALL
|
+$60.1M |
| 4 |
Salesforce
CRM
|
+$60M |
| 5 |
Northrop Grumman
NOC
|
+$54.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.66% |
| 2 | Financials | 14.5% |
| 3 | Healthcare | 12.57% |
| 4 | Consumer Discretionary | 12.57% |
| 5 | Industrials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Crocs
CROX
$6.55B
| $1.25M | 0.01% |
15,546
+8,564
| +123% | +$653K |
|
927
West Pharmaceutical
WST
$24.9B
| $1.25M | 0.01% |
4,434
+408
| +10% | +$117K |
|
928
DuPont de Nemours
DD
$19.2B
| $1.25M | 0.01% |
12,870
-37,208
| -74% | -$3.57M |
|
929
ON Semiconductor
ON
$31.6B
| $1.25M | 0.01% |
29,912
-5,685
| -16% | -$218K |
|
|
JNPR
930
DELISTED
Juniper Networks
JNPR
| $1.24M | 0.01% |
49,100
+6,930
| +16% | +$171K |
|
|
ABMD
931
DELISTED
Abiomed Inc
ABMD
| $1.24M | 0.01% |
3,897
+166
| +4% | +$53.1K |
|
|
ALXN
932
DELISTED
Alexion Pharmaceuticals
ALXN
| $1.24M | 0.01% |
8,125
-34
| -0.4% | -$5.26K |
|
933
Dolby
DLB
$5.79B
| $1.24M | 0.01% |
12,553
+2,844
| +29% | +$272K |
|
934
Darling Ingredients
DAR
$9.44B
| $1.24M | 0.01% |
16,822
-10,200
| -38% | -$701K |
|
935
Equifax
EFX
$21.4B
| $1.23M | 0.01% |
6,812
+115
| +2% | +$20.3K |
|
936
DMC Global
BOOM
$157M
| $1.23M | 0.01% |
22,692
| – | – |
|
937
Applied Industrial Technologies
AIT
$13.3B
| $1.23M | 0.01% |
13,438
-6,731
| -33% | -$571K |
|
|
EBTC
938
DELISTED
Enterprise Bancorp
EBTC
| $1.22M | 0.01% |
37,600
+1,252
| +3% | +$36.7K |
|
939
Hewlett Packard
HPE
$70.5B
| $1.22M | 0.01% |
77,485
-8,210
| -10% | -$114K |
|
940
Terex
TEX
$7.74B
| $1.22M | 0.01% |
26,386
+19,912
| +308% | +$816K |
|
|
HZNP
941
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $1.21M | 0.01% |
13,167
-7,230
| -35% | -$610K |
|
942
ABM Industries
ABM
$2.84B
| $1.21M | 0.01% |
23,703
+21,774
| +1,129% | +$955K |
|
943
Avista
AVA
$3.24B
| $1.2M | 0.01% |
25,192
+309
| +1% | +$12.7K |
|
|
TEN
944
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $1.2M | 0.01% |
111,514
+94,713
| +564% | +$1.04M |
|
945
Huazhu Hotels Group
HTHT
$13B
| $1.19M | 0.01% |
21,734
+18,999
| +695% | +$1.02M |
|
946
STAG Industrial
STAG
$7.19B
| $1.19M | 0.01% |
35,435
+939
| +3% | +$30K |
|
947
Realty Income
O
$59.1B
| $1.19M | 0.01% |
19,306
+2,467
| +15% | +$146K |
|
948
Carrier Global
CARR
$52.8B
| $1.19M | 0.01% |
28,102
-452,563
| -94% | -$17.6M |
|
949
Amneal Pharmaceuticals
AMRX
$5.79B
| $1.18M | 0.01% |
+175,861
| New | +$975K |
|
|
PZN
950
DELISTED
Pzena Investment Management, Inc. Class A
PZN
| $1.18M | 0.01% |
112,222
-4,549
| -4% | -$42.8K |
|
Similar funds
GAM
PPF
Panagora Asset Management's Q1 2021 Portfolio in Review
As of Q1 2021, Panagora Asset Management held 3,154 positions worth $17.8B, up 5.4% from $16.9B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Panagora Asset Management's Q1 2021 filing shows 338 new, 1,006 increased, 790 reduced and 311 closed positions. Its largest new stake was Fate Therapeutics: 162,596 shares worth $13.4M. The largest sale was Walmart Inc, an estimated $90.6M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
- Panagora Asset Management's largest Q1 2021 buy was Fate Therapeutics: 162,596 shares worth $13.4M.
- Panagora Asset Management added most to AbbVie in Q1 2021, an estimated $69.1M increase.
- Panagora Asset Management's biggest Q1 2021 reduction was Walmart Inc, cutting an estimated $90.6M.
- Panagora Asset Management fully exited iShares MSCI Taiwan ETF in Q1 2021, selling an estimated $9.74M.
- Panagora Asset Management's ten largest holdings make up 23% of its $17.8B portfolio in Q1 2021.
- Panagora Asset Management opened 338 new positions and closed 311 in Q1 2021.
- Panagora Asset Management's portfolio value rose 5.4% quarter-over-quarter to $17.8B.
Based on Panagora Asset Management's 13F filing for Q1 2021, filed 12 May 2021.